Trinity Biotech (TRIB) Inventory Average (2009 - 2025)

Trinity Biotech's Inventory Average history runs 17 years deep, the most recent figure standing at $19.5 million for Q4 2025.

• In Q4 2025, Inventory Average fell 5.39% year-over-year to $19.5 million; the TTM figure through Dec 2025 stood at $19.5 million (down 5.39% YoY), while the FY2025 annual figure was $19.1 million, up 86.04% from the prior year.
• Inventory Average came in at $19.5 million for Q4 2025 at Trinity Biotech, down from $19.8 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $36.1 million in Q2 2021 to a low of $11.0 million in Q4 2023.
• A 5-year average of $24.2 million and a median of $22.6 million in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average plunged 52.15% in 2023 and soared 86.83% in 2024, its largest moves.
• Trinity Biotech's Inventory Average stood at $30.6 million in 2021, then declined by 24.79% to $23.0 million in 2022, then slumped by 52.15% to $11.0 million in 2023, then surged by 86.83% to $20.6 million in 2024, then dropped by 5.39% to $19.5 million in 2025.
• According to Business Quant data, Inventory Average over the past three periods registered $19.5 million, $19.8 million, and $20.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison